Erratum: Editor's note: Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment (Clin Cancer Res (2019) 17(7563–7573)Doi:10.1158/1078-0432.CCR-11-1707)

Jilong Yang, Antti Ylip€a€a, Yan Sun, Hong Zheng, Kexin Chen, Matti Nykter, Jonathan Trent, Nancy Ratner, Dina C. Lev, Wei Zhang

Research output: Contribution to journalComment/debate

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 3A, Western blot similarities exist in the EGFR (24, 48, and 72 hours), PI3K (IGF1R siRNA: 24 and 72 hours), pERK (Control siRNA: 48 and 72 hours), and Actin (24 and 72 hours) panels. Original data are not available for review, and the authors stand by the conclusions of the article.

Original languageEnglish
Pages (from-to)3195
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number10
DOIs
StatePublished - 2019

Fingerprint

Dive into the research topics of 'Erratum: Editor's note: Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment (Clin Cancer Res (2019) 17(7563–7573)Doi:10.1158/1078-0432.CCR-11-1707)'. Together they form a unique fingerprint.

Cite this